Skip to main content
. 2022 Jan 3;22:13. doi: 10.1186/s12887-021-03069-1

Table 2.

Estimates of life-years after diagnosis, QALYs (Discounted) and Costs (Discounted)

Variable Intervention Control Delta (Intervention-Control)
No Radiation Benefit
Life-years 40.08 (33.19;45.76) 39.01 (32.94;44.38) 1.07 (0;2.39)
QALY 11 (9.16;12.59) 10.62 (9.04;12.03) 0.38 (0.08;0.77)
Total Cost $215,358 ($159,507; $232,728) $216,742 ($161,250; $234,069) $-1384 ($-3486; $1204)
PLGG $90,839 ($75,023; $108,612) $90,244 ($74,885; $107,176) $595 ($106; $2083)
AE $124,519 ($76,439; $151,351) $126,498 ($78,418; $153,232) $-1979 ($-4414; $1017)
Radiation Benefit
Life-years 42.05 (34.98;47.29) 41.44 (35.8;46.09) 0.61 (−0.78;2.25)
QALY 11.46 (9.69;12.91) 11.18 (9.68;12.49) 0.28 (−0.11;0.72)
Total Cost $217,393 ($157,671; $236,003) $218,624 ($155,869; $237,155) $-1232 ($-3508; $1938)
PLGG $78,899 ($68,624; $91,119) $75,259 ($66,745; $85,262) $3640 ($984; $8397)
AE $138,494 ($81,832; $160,740) $143,366 ($84,549; $164,863) $-4872 ($-10,600; $-146)

Estimates reported with 95% Confidence Interval in brackets. All costs are given in Canadian dollars

QALY: Quality-adjusted Life Years; PLGG: Pediatric Low-Grade Glioma; AE: Adverse Events